Low-dose IL-2 as a therapeutic agent for tolerance induction

被引：0
|
作者：
Malek, Thomas R. [1 ,2 ]
Pugliese, Alberto [1 ,2 ,3 ]
机构：
[1] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA
[3] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Miami, FL 33101 USA
来源：
IMMUNOTHERAPY | 2011年 / 3卷 / 11期
关键词：
IL-2; tolerance; T regulatory cells; Type; 1; diabetes; REGULATORY T-CELLS; INTERLEUKIN-2; PRODUCTION; DIABETES-MELLITUS; COMPLEXES; EXPANSION; IMMUNITY;
D O I：
10.2217/IMT.11.120
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1281 / 1284
页数：4
相关论文
共 50 条
  • [21] Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity
    Zhou, Pengcheng
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 67 : 80 - 88
  • [22] Low-dose IL-2 in the treatment of immune-related diseases
    Zhang, Jiakui
    Huang, Yong
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [23] Therapeutic potential of low-dose IL-2 in a chronic GVHD patient by in vivo expansion of regulatory T cells
    Kim, Nayoun
    Jeon, Young-Woo
    Nam, Young-Sun
    Lim, Jung-Yeon
    Im, Keon-Il
    Lee, Eun-Sol
    Cho, Seok-Goo
    CYTOKINE, 2016, 78 : 22 - 26
  • [24] Combination therapy of low dose regulatory T cells and low dose IL-2 for transplant tolerance
    Cross, Amy
    Short, Sarah M.
    Hur, Eun Mi
    Ramirez-Valle, Francisco
    Hester, Joanna
    Issa, Fadi
    TRANSPLANTATION, 2024, 108 (9S)
  • [25] Combination therapy of low dose regulatory T cells and low dose IL-2 for transplant tolerance
    Cross, Amy
    Short, Sarah M.
    Hur, Eun Mi
    Ramirez-Valle, Francisco
    Hester, Joanna
    Issa, Fadi
    TRANSPLANTATION, 2024, 108 (09) : 377 - 377
  • [26] In vitro modulation of T cells in myasthenia gravis by low-dose IL-2
    Cebi, Merve
    Cakar, Arman
    Durmus, Hacer
    Akan, Onur
    Aysal, Fikret
    Parman, Yesim
    Saruhan-Direskeneli, Guher
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (11)
  • [27] EFFICACY AND SAFETY OF LOW-DOSE IL-2 IN PATIENTS WITH MULTIPLE MYOSITIS/DERMATOMYOSITIS
    Sun, He-Hua
    Zhang, Sheng-xiao
    Wang, Jia
    Hao, Yu-Fei
    Liu, Guang-Ying
    Wang, Caihong
    Gao, Chong
    Li Xiao-Feng
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 201 - 201
  • [28] Low-dose IL-2 therapy — a complex scenario that remains to be further explored
    Jens Y. Humrich
    Gabriela Riemekasten
    Nature Reviews Rheumatology, 2017, 13 : 386 - 386
  • [29] Low-dose IL-2 therapy - a complex scenario that remains to be further explored
    Humrich, Jens Y.
    Riemekasten, Gabriela
    NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (06) : 386 - 386
  • [30] LOW-DOSE OF IL-2 FAILS TO PREVENT SPONDYLOARTHRITIS DEVELOPMENT IN EXPERIMENTAL MODEL
    Araujo, L. M.
    Jouhault, Q.
    Fert, I
    Bouiller, I
    Chiocchia, G.
    Lebouteiller, C.
    Breban, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 816 - 816
12345